A
A

Price • Artiva Biotherapeutics

ARTV

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.

Historical stock price chart and annual return over the past years

-53%

8 months

% Total

ARTV